Doxorubicin

transferrin ; Homo sapiens







87 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34935843 Enhanced anti-tumor activity of a drug through pH-triggered release and dual targeting by calcium phosphate-covered mesoporous silica vehicles. 2022 Jan 19 10
2 35386209 Preliminary Study on the Therapeutic Effect of Doxorubicin-Loaded Targeting Nanoparticles on Glioma. 2022 4
3 35522032 Adenoviral Vector for Enhanced Prostate Cancer Specific Transferrin Conjugated Drug Targeted Therapy. 2022 May 25 2
4 33177062 Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors. 2021 Feb 1 2
5 33633284 Doxorubicin-transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells. 2021 Feb 25 1
6 33984456 Multifunctional PLGA nanoparticles combining transferrin-targetability and pH-stimuli sensitivity enhanced doxorubicin intracellular delivery and in vitro antineoplastic activity in MDR tumor cells. 2021 Sep 1
7 34076419 An Advanced In Situ Magnetic Resonance Imaging and Ultrasonic Theranostics Nanocomposite Platform: Crossing the Blood-Brain Barrier and Improving the Suppression of Glioblastoma Using Iron-Platinum Nanoparticles in Nanobubbles. 2021 Jun 16 1
8 34328322 Sterically Bulky Caging of Transferrin for Photoactivatable Intracellular Delivery. 2021 Aug 18 3
9 31923538 Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo. 2020 Mar 10 1
10 32027209 Bifunctional Aptamer-Doxorubicin Conjugate Crosses the Blood-Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells. 2020 Apr 2
11 32259795 Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen. 2020 Apr 7 1
12 33061378 Dual-Effect of Magnetic Resonance Imaging Reporter Gene in Diagnosis and Treatment of Hepatocellular Carcinoma. 2020 1
13 33321722 Transferrin-Bound Doxorubicin Enhances Apoptosis and DNA Damage through the Generation of Pro-Inflammatory Responses in Human Leukemia Cells. 2020 Dec 10 3
14 30717256 Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells. 2019 Feb 1 16
15 31102765 Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo. 2019 Jul 1 3
16 31423412 Bacterial magnetosomes loaded with doxorubicin and transferrin improve targeted therapy of hepatocellular carcinoma. 2019 6
17 31433156 Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma. 2019 Sep 18 1
18 31654226 Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate. 2019 Oct 25 1
19 29278317 Transferrin-Copper Nanocluster-Doxorubicin Nanoparticles as Targeted Theranostic Cancer Nanodrug. 2018 Jan 31 1
20 29293251 Stable nanoconjugates of transferrin with alloyed quaternary nanocrystals Ag-In-Zn-S as a biological entity for tumor recognition. 2018 Jan 18 1
21 29433357 Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. 2018 Nov 6
22 30087932 Development of Doxorubicin-Loaded Magnetic Silica-Pluronic F-127 Nanocarriers Conjugated with Transferrin for Treating Glioblastoma across the Blood-Brain Barrier Using an in Vitro Model. 2018 Jul 31 1
23 28075466 Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment. 2017 Feb 4
24 28088015 Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery. 2017 Apr 1 4
25 28107619 Peptide-Based Stealth Nanoparticles for Targeted and pH-Triggered Delivery. 2017 Feb 15 1
26 28183621 A transferrin variant as the targeting ligand for polymeric nanoparticles incorporated in 3-D PLGA porous scaffolds. 2017 Apr 1 2
27 28653773 A Target-Directed Chemo-Photothermal System Based on Transferrin and Copolymer-Modified MoS2 Nanoplates with pH-Activated Drug Release. 2017 Aug 22 1
28 28732901 Multiple polysaccharide-drug complex-loaded liposomes: A unique strategy in drug loading and cancer targeting. 2017 Oct 1 1
29 26036724 Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma. 2016 May 2
30 26942448 Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin. 2016 Oct 3
31 27251028 Development of Core-Shell Nanostructures by In Situ Assembly of Pyridine-Grafted Diblock Copolymer and Transferrin for Drug Delivery Applications. 2016 Jul 11 4
32 27264717 Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid. 2016 Aug 3
33 27714111 Transferrin conjugated nontoxic carbon dots for doxorubicin delivery to target pediatric brain tumor cells. 2016 Sep 22 4
34 29227592 Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents. 2016 Jan-Feb 1
35 25243866 Aloin: a natural antitumor anthraquinone glycoside with iron chelating and non-atherogenic activities. 2015 Jan 1
36 26328315 Delivery of Transferrin-Conjugated Polysaccharide Nanoparticles in 9L Gliosacoma Cells. 2015 Jan 2
37 26456252 The targeted delivery of doxorubicin with transferrin-conjugated block copolypeptide vesicles. 2015 Dec 30 3
38 26604751 Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy. 2015 3
39 24055890 Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells. 2014 Mar 4
40 24242938 Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier. 2014 May 2
41 24363124 Quantitative subcellular study of transferrin receptor-targeted doxorubicin and its metabolite in human breast cancer cells. 2014 Dec 1
42 24387131 The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems. 2014 1
43 24804644 Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy. 2014 Jul 1
44 24905399 Transferrin targeted core-shell nanomedicine for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinoma. 2014 Nov 3
45 24998637 Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines. 2014 Sep 5 2
46 25187713 Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. 2014 2
47 25308442 Genotoxic effect of doxorubicin-transferrin conjugate on human leukemia cells. 2014 Sep 1 10
48 25312849 Changes in the activity of antioxidant barrier after treatment of K562 and CCRF-CEM cell lines with doxorubicin-transferrin conjugate. 2014 Dec 4
49 23204307 Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery. 2013 Jun 2
50 23628475 Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes. 2013 Jul 2